🇺🇸
United States · US · US:71336-1003_1791a81a-d261-4b66-b699-273afe02c380
AMVUTTRA
Orange BookUNIISPLATC N07XX18
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAlnylam Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeN07XX18
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1171336100311 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS
Annotations
UNII (FDA Substance ID)
28O0WP6Z1P
VUTRISIRAN SODIUM
RxCUI 2605574
Orange Book
N215515
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "28O0WP6Z1P",
"rxcui": "2605574",
"inchikey": null,
"display_name": "VUTRISIRAN SODIUM",
"substance_type": "nucleicAcid",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"8db0facb-81b6-4006-9239-27dc6409c5d3": {
"match": "brand_token",
"title": "AMVUTTRA (VUTRISIRAN) INJECTION [ALNYLAM PHARMACEUTICALS, INC.]",
"spl_version": "8",
"published_date": "2025-11-17"
}
},
"productid": "71336-1003_1791a81a-d261-4b66-b699-273afe02c380",
"productndc": "71336-1003",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "215515",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)",
"product_no": "001",
"approval_date": "Jun 13, 2022"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "VUTRISIRAN SODIUM",
"proprietary_name": "AMVUTTRA",
"active_ingred_unit": "mg/.5mL",
"application_number": "NDA215515",
"marketing_category": "NDA",
"nonproprietary_name": "VUTRISIRAN",
"start_marketing_date": "20220613",
"active_numerator_strength": "25"
}Related drugs
Other records sharing ATC code N07XX18.
Access this data programmatically
Query AMVUTTRA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.